Europska Unija - hrvatski - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. trostruki kombinovanu terapiju) kao dodatak prehrani i vježbe kod pacijenata, nedovoljno kontroliranim o njihovo maksimalno переносимой doze метформина i sulfonilurejom. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Europska Unija - hrvatski - EMA (European Medicines Agency)

astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - antianemijski pripravci - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).

Europska Unija - hrvatski - EMA (European Medicines Agency)

teva pharma b.v. - clopidogrel, acetylsalicylic acid - acute coronary syndrome; myocardial infarction - kombinacije - klopidogrel/acetilsalicilna kiselina teva je indiciran za prevenciju aterotrombotskih događaja u odraslih bolesnika koji već uzimaju klopidogrel i acetilsalicilnu kiselinu (ask). Клопидогрел/Ацетилсалициловая kiselina tewa je fiksna kombinacija doza lijekova za nastavak terapije:ne porast segmenta st akutna koronarna sindrom (nestabilna angina, ili ne‑q‑infarkt miokarda), uključujući i bolesnike koji su patili стентирование nakon чрескожных koronarnih interventionst porast u segmentu akutnog infarkta miokarda u liječenju pacijenata koji imaju pravo na thrombolytic terapije.

Europska Unija - hrvatski - EMA (European Medicines Agency)

mylan ireland limited - rivaroksaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotska sredstva - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers.  rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events.  ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery.  treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult   patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

oktal pharma d.o.o. sarajevo - amlodipin, atorvastatin, Периндоприл - filmom obložena tableta - 10 mg/1 tableta+ 5 mg/1 tableta+ 5 mg/1 tableta - jedna filmom obložena tableta sadrži: 10 mg atorvastatina (što odgovara 10,82 mg atorvastatin kalcij trihidrata), 5 mg perindopril arginina (što odgovara 3,40 mg perindoprila) i 5 mg amlodipina (što odgovara 6,94 mg amlodipin besilata)

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

oktal pharma d.o.o. sarajevo - amlodipin, atorvastatin, Периндоприл - filmom obložena tableta - 20 mg/1 tableta+ 5 mg/1 tableta+ 5 mg/1 tableta - jedna filmom obložena tableta sadrži: 20 mg atorvastatina (što odgovara 21,64 mg atorvastatin kalcij trihidrata), 5 mg perindopril arginina (što odgovara 3,40 mg perindoprila) i 5 mg amlodipina (što odgovara 6,94 mg amlodipin besilata)

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

oktal pharma d.o.o. sarajevo - amlodipin, atorvastatin, Периндоприл - filmom obložena tableta - 20 mg/1 tableta+ 10 mg/1 tableta+ 5 mg/1 tableta - jedna filmom obložena tableta sadrži: 20 mg atorvastatina (što odgovara 21,64 mg atorvastatin kalcij trihidrata), 10 mg perindopril arginina (što odgovara 6,79 mg perindoprila) i 5 mg amlodipina (što odgovara 6,94 mg amlodipin besilata)

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

oktal pharma d.o.o. sarajevo - amlodipin, atorvastatin, Периндоприл - filmom obložena tableta - 20 mg/1 tableta+ 10 mg/1 tableta+ 10 mg/1 tableta - jedna filmom obložena tableta sadrži: 20 mg atorvastatina (što odgovara 21,64 mg atorvastatin kalcij trihidrata), 10 mg perindopril arginina (što odgovara 6,79 mg perindoprila) i 10 mg amlodipina (što odgovara 13,87 mg amlodipin besilata)

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

oktal pharma d.o.o. sarajevo - amlodipin, atorvastatin, Периндоприл - filmom obložena tableta - 40 mg/1 tableta+ 10 mg/1 tableta+ 10 mg/1 tableta - jedna filmom obložena tableta sadrži: 40 mg atorvastatina (što odgovara 43,28 mg atorvastatin kalcij trihidrata), 10 mg perindopril arginina (što odgovara 6,79 mg perindoprila) i 10 mg amlodipina (što odgovara 13,87 mg amlodipin besilata)

Europska Unija - hrvatski - EMA (European Medicines Agency)

merck sharp dohme limited - lamivudin, ралтегравир kalija - hiv infekcije - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - dutrebis je indiciran u kombinaciji s drugim anti‑retroviral lijekovima za liječenje humane imunodeficijencije (hiv‑1) infekcija u odraslih, adolescenata i djece u dobi od 6 godina i tjelesne težine najmanje 30 kg bez sadašnjosti ili prošlosti dokaz virusne otpornosti na antivirusne lijekove institucije (rezistencije strand prijenos inhibitor) i eng. (inhibitor reverzne transkriptaze nukleozida) klase (vidjeti dio 4. 2, 4. 4 i 5.